[go: up one dir, main page]

AR006308A1 - Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador. - Google Patents

Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.

Info

Publication number
AR006308A1
AR006308A1 ARP970100422A ARP970100422A AR006308A1 AR 006308 A1 AR006308 A1 AR 006308A1 AR P970100422 A ARP970100422 A AR P970100422A AR P970100422 A ARP970100422 A AR P970100422A AR 006308 A1 AR006308 A1 AR 006308A1
Authority
AR
Argentina
Prior art keywords
composition
biologically effective
effective compound
dispensing system
aqueous
Prior art date
Application number
ARP970100422A
Other languages
English (en)
Original Assignee
Cosmoferm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27443289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR006308(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cosmoferm Bv filed Critical Cosmoferm Bv
Publication of AR006308A1 publication Critical patent/AR006308A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
    • B05B11/1081—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping
    • B05B11/1084—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping each liquid or other fluent material being pumped by a separate pump

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un sistemas dispensador que permite la aplicación de una composición acuosa que contiene un compuesto biológicamente efectivo estabilizadoadecuadamente. Se utiliza un sistema dispensador de dos cámaras en donde están contenidas de forma sseparada una composición que comprende uncompuesto biológicamente efectivo y una composición básica acuosa. El sistema dispensador entrega ambas composiciones simultáneamente, con lo cual lascomposiciones se mezclan para dar como resultado una composición final adecuada para una aplicación directa, de dicho compuesto biológicamenteefectivo en su forma activa. La primer y segunda composición se entregan en una relación que varía de 1:1 a 1:50. Adicionalmente la composición puedec omprenderotro ingrediente activo. También puede contener agentes para aumentar la viscosidad. El compuesto biológicamente activo son inestablesen la formulación acuosa final en la cual se debería aplicar. Preferentemente dichos compuestos pueden ser enzimas,antibióticos, vitaminas,dihidroxiacetonas, etc. Se refiere también a un método para estabilizar físicamente una composición que comprende adicionar un agente para aumentarla viscosidad a la composición de un compuesto biol ógicamente efectivoformulado en forma de partículas. Otro objeto es una composición acuosaque comprende el compuesto biológicamente efectivo. Finalmente describe el uso del sistema dispensador para el empleo de aplicaciones tópicas del compuesto biológicamenteefectivo.
ARP970100422A 1996-01-31 1997-02-03 Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador. AR006308A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP96200190 1996-01-31
EP96200594 1996-03-08
EP96201713 1996-06-21
EP96202781 1996-10-03

Publications (1)

Publication Number Publication Date
AR006308A1 true AR006308A1 (es) 1999-08-25

Family

ID=27443289

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100422A AR006308A1 (es) 1996-01-31 1997-02-03 Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.

Country Status (16)

Country Link
US (1) US6117433A (es)
EP (1) EP0817613B1 (es)
JP (1) JPH11503465A (es)
KR (1) KR100517060B1 (es)
CN (1) CN1140261C (es)
AR (1) AR006308A1 (es)
AT (1) ATE291897T1 (es)
AU (1) AU1721697A (es)
BR (1) BR9702049B1 (es)
CA (1) CA2216169C (es)
DE (1) DE69732881T2 (es)
ES (1) ES2237789T3 (es)
ID (1) ID18666A (es)
MX (1) MX9707487A (es)
PT (1) PT817613E (es)
WO (1) WO1997027841A1 (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5947335A (en) * 1996-10-15 1999-09-07 Lever Brothers Company Dual compartment package
US6082588A (en) * 1997-01-10 2000-07-04 Lever Brothers Company, Division Of Conopco, Inc. Dual compartment package and pumps
EP0996428A2 (en) * 1997-07-08 2000-05-03 Dsm N.V. Topical application of a combination of benzoyl peroxide and a second active ingredient
KR100351620B1 (ko) * 1999-07-09 2002-09-10 주식회사대성미생물연구소 3차 결정구조의 내열성 효소
KR100340086B1 (ko) * 1999-08-27 2002-06-12 안용찬 비듬방지용 샴푸조성물
US6585984B1 (en) * 2000-03-03 2003-07-01 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Dual composition cosmetic product with a concentration sensitive and an incompatible active respectively placed within first and second compositions
AU2001255487A1 (en) * 2000-04-21 2001-11-07 Nature's Cure Salicylic acid acne spray formulations and methods for treating acne with same
US20030206897A1 (en) * 2000-09-13 2003-11-06 The Procter & Gamble Company Cosmetic compositions
EP1317249A1 (en) * 2000-09-13 2003-06-11 The Procter & Gamble Company Cosmetic compositions
AU2000274827A1 (en) * 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic compositions
WO2002022100A1 (en) * 2000-09-13 2002-03-21 The Procter & Gamble Company Cosmetic method
AU2000274825A1 (en) * 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic method
JP2004509861A (ja) * 2000-09-13 2004-04-02 ザ、プロクター、エンド、ギャンブル、カンパニー 皮膚及び／又は毛髪を処理するための化粧方法
JP2002326924A (ja) * 2001-05-07 2002-11-15 Hayashibara Biochem Lab Inc 洗顔料
US7364565B2 (en) * 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
ATE423104T1 (de) * 2001-11-03 2009-03-15 Astrazeneca Ab Quinazolin derivate als antitumor-mittel
CA2416305A1 (en) * 2002-01-31 2003-07-31 Davies, John Shaving, after-shave, and skin conditioning compositions
US20080152722A1 (en) * 2002-01-31 2008-06-26 Norburn Robert B Skin care composition
US20080152613A1 (en) * 2002-01-31 2008-06-26 Norburn Robert B Method for manufacturing a skin care composition
TWI324597B (en) * 2002-03-28 2010-05-11 Astrazeneca Ab Quinazoline derivatives
US6924285B2 (en) * 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
FR2840215B1 (fr) * 2002-06-03 2004-08-27 Oreal Composition contenant un actif susceptible d'etre oxyde par un hydroperoxyde, une lipoxygenase et un substrat et procede mettant en oeuvre cette composition
DE10241073A1 (de) * 2002-09-05 2004-03-11 Beiersdorf Ag Kosmetikum mit aktivierbaren Pflegekomponenten
GB0309009D0 (en) * 2003-04-22 2003-05-28 Astrazeneca Ab Quinazoline derivatives
GB0309850D0 (en) * 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
CA2477922C (en) * 2003-08-20 2010-10-26 Seikagaku Corporation Stabilizing agent for enzymes
DE10342211A1 (de) * 2003-09-12 2005-04-07 Beiersdorf Ag Kosmetikum
GB0321648D0 (en) * 2003-09-16 2003-10-15 Astrazeneca Ab Quinazoline derivatives
JP2007505873A (ja) * 2003-09-16 2007-03-15 アストラゼネカ アクチボラグ チロシンキナーゼ阻害剤としてのキナゾリン誘導体
US8318752B2 (en) * 2003-09-19 2012-11-27 Astrazeneca Ab 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)piperidin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same
EP1670782B1 (en) * 2003-09-19 2007-02-14 AstraZeneca AB Quinazoline derivatives
CA2540008A1 (en) * 2003-09-25 2005-04-07 Astrazeneca Ab Quinazoline derivatives
WO2005032729A1 (ja) * 2003-10-03 2005-04-14 Kao Corporation 吐出装置
EA200600745A1 (ru) * 2003-10-10 2006-10-27 Космедикал Апс Ингибирование роста волос
CN1870965A (zh) * 2003-10-31 2006-11-29 宝洁公司 提供共混组合物的方法
GB0326459D0 (en) * 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
JP2008501675A (ja) * 2004-06-04 2008-01-24 アストラゼネカ アクチボラグ Ｅｒｂｂ受容体型チロシンキナーゼとしてのキナゾリン誘導体
JP2005350384A (ja) * 2004-06-09 2005-12-22 Blc:Kk 基礎化粧方法
CN101005853B (zh) 2004-07-26 2011-05-04 莫茨药物股份两合公司 包含肉毒杆菌神经毒素的治疗组合物
JP4881875B2 (ja) 2004-12-14 2012-02-22 アストラゼネカ アクチボラグ 抗腫瘍剤としてのピラゾロピリミジン化合物
KR20070107151A (ko) * 2005-02-26 2007-11-06 아스트라제네카 아베 티로신 키나제 억제제로서의 퀴나졸린 유도체
GB0504474D0 (en) * 2005-03-04 2005-04-13 Astrazeneca Ab Chemical compounds
GB0508717D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
GB0508715D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
US7378084B2 (en) * 2005-07-01 2008-05-27 Playtex Products, Inc. Sunless tanning composition and method of sunless tanning
EP1931362A2 (en) * 2005-08-10 2008-06-18 Maya-Biotech Ltd. Drug delivery system for topical administration
DE602006018331D1 (de) * 2005-09-20 2010-12-30 Astrazeneca Ab 4-(1h-indazol-5-ylamino)chinazolinverbindungen als inhibitoren der erbb-rezeptortyrosinkinase zur behandlung von krebs
USD543864S1 (en) 2005-09-20 2007-06-05 Cho Sean H Dual dispenser package with single actuator
WO2007034143A1 (en) * 2005-09-20 2007-03-29 Astrazeneca Ab Quinazoline derivatives as anticancer agents
USD543865S1 (en) 2005-09-20 2007-06-05 Walters Peter J Dual dispenser package with dual actuators
WO2007063291A1 (en) * 2005-12-02 2007-06-07 Astrazeneca Ab 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
ATE443053T1 (de) * 2005-12-02 2009-10-15 Astrazeneca Ab Als inhibitoren von erbb-tyrosinkinase verwendete chinazoleinderivate
EP1921070A1 (de) * 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
BRPI0807234A2 (pt) * 2007-02-06 2014-06-03 Boehringer Ingelheim Int Heterociclos bicíclicos, composições farmacêuticas que contêm estes compostos, o uso dos mesmos e processos para a preparação dos mesmos
US8569221B2 (en) * 2007-08-30 2013-10-29 Kimberly-Clark Worldwide, Inc. Stain-discharging and removing system
KR20100111291A (ko) * 2008-02-07 2010-10-14 베링거 인겔하임 인터내셔날 게엠베하 스피로사이클릭 헤테로사이클, 상기 화합물을 함유하는 약제, 이의 용도 및 이의 제조 방법
MY183041A (en) 2008-05-13 2021-02-08 Astrazeneca Ab Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- {[1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
CA2733153C (en) * 2008-08-08 2016-11-08 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
US20120076742A1 (en) * 2010-04-21 2012-03-29 Phillips D Howard Topical drug delivery system with dual carriers
CN104254370A (zh) 2011-12-20 2014-12-31 欧瑞莲研发有限公司 具有防衰老活性的化合物
US9931656B2 (en) * 2014-04-18 2018-04-03 The Clorox Company Dual chamber spray dispenser
CN107177567B (zh) * 2016-02-16 2018-07-03 上海青瑞食品科技有限公司 一种液体酶制剂及制备方法
EP3210630A1 (en) 2016-02-29 2017-08-30 G.L. Pharma GmbH Abuse-deterrent pharmaceutical compositions
EP3231420A1 (en) 2016-02-29 2017-10-18 G.L. Pharma GmbH Abuse-deterrent pharmaceutical compositions
EP3210596A1 (en) 2016-02-29 2017-08-30 G.L. Pharma GmbH Abuse-deterrent pharmaceutical composition
FR3052035B1 (fr) 2016-06-02 2020-10-09 Oreal Systeme de distribution d'un produit cosmetique
WO2018177730A1 (de) 2017-03-27 2018-10-04 Evonik Degussa Gmbh Verfahren und erzeugnis zur herstellung ceramidhaltiger formulierungen
JP7080247B2 (ja) * 2017-03-31 2022-06-03 アモーレパシフィック コーポレーション アメントフラボンの安定度が向上した透明または半透明の化粧料組成物
WO2018195415A1 (en) * 2017-04-21 2018-10-25 Phi Therapeutics, Inc. Compositions comprising propionibacterium acnes bacteriophages for treating acne
IT201900006994A1 (it) * 2019-05-20 2020-11-20 Biodermol Ambiente S R L Ceppi batterici per uso industriale
US20230017360A1 (en) * 2019-11-22 2023-01-19 Samyang Holdings Corporation Kit for preparing nanoparticle composition for drug delivery
KR20230029260A (ko) * 2021-08-24 2023-03-03 (주)아모레퍼시픽 효소 손상을 방지하는 화장료 조성물 및 이를 저장하는 화장품 용기

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6318M (es) * 1967-04-04 1968-09-23
FR2032202A5 (es) * 1969-02-21 1970-11-20 Oreal
US3834075A (en) * 1973-02-12 1974-09-10 Tre X Injector Syst Co Tree trunk pressure feeding device
US3992813A (en) * 1975-07-07 1976-11-23 Freshel David C Tree treating system
US4243543A (en) * 1979-05-11 1981-01-06 Economics Laboratory, Inc. Stabilized liquid enzyme-containing detergent compositions
US4556554A (en) * 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
AU3667189A (en) * 1988-06-23 1990-01-04 Unilever Plc Enzyme-containing liquid detergents
US4959179A (en) * 1989-01-30 1990-09-25 Lever Brothers Company Stabilized enzymes liquid detergent composition containing lipase and protease
WO1991000094A1 (en) * 1989-06-28 1991-01-10 Finn Tranberg A new papaverine injection system
ES2044718T3 (es) * 1989-12-21 1994-01-01 Novo Nordisk As Preparacion que contiene enzimas y detergente que contiene dicha preparacion.
DE4023601A1 (de) * 1990-07-25 1992-01-30 Henkel Kgaa Fluessige enzymzubereitung
DE4121820A1 (de) * 1991-07-02 1993-01-07 Basf Ag Mikrokapseldispersionen
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US5252312A (en) * 1992-09-30 1993-10-12 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Package effervescible composition
AU687803B2 (en) * 1993-03-31 1998-03-05 Schering-Plough Healthcare Products, Inc. Sunless tanning method and apparatus
JPH09506127A (ja) * 1993-12-03 1997-06-17 バックマン・ラボラトリーズ・インターナショナル・インコーポレーテッド ブロックコポリマーによる酵素安定化
US5843409A (en) * 1994-08-08 1998-12-01 Colgate Palmolive Company Two component dentifrice for the treatment of dentinal hypersensitivity
FR2725897B1 (fr) * 1994-10-24 1996-12-06 Oreal Produit pour application topique contenant une lipase et un precurseur d'actif

Also Published As

Publication number Publication date
MX9707487A (es) 1997-11-29
CN1140261C (zh) 2004-03-03
JPH11503465A (ja) 1999-03-26
PT817613E (pt) 2005-06-30
US6117433A (en) 2000-09-12
BR9702049A (pt) 1998-01-13
BR9702049B1 (pt) 2010-08-10
AU1721697A (en) 1997-08-22
DE69732881T2 (de) 2006-04-06
CN1178460A (zh) 1998-04-08
ATE291897T1 (de) 2005-04-15
KR19980703467A (ko) 1998-11-05
ES2237789T3 (es) 2005-08-01
DE69732881D1 (de) 2005-05-04
EP0817613A1 (en) 1998-01-14
WO1997027841A1 (en) 1997-08-07
KR100517060B1 (ko) 2006-05-25
CA2216169C (en) 2007-01-23
EP0817613B1 (en) 2005-03-30
CA2216169A1 (en) 1997-08-07
ID18666A (id) 1998-04-30

Similar Documents

Publication Publication Date Title
AR006308A1 (es) Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.
BR9810985A (pt) Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
PT2455083E (pt) Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase
CA2338358A1 (en) Compounds and compositions for delivering active agents
EP1226109A4 (en) PHENYLAMINE CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DISPENSING ACTIVE AGENTS
GR3006146T3 (es)
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
BR0112094A (pt) Produtos de confeitaria contendo ingredientes ativos
UA39896C2 (uk) Фармацевтична або ветеринарна композиція мупіроцину та спосіб її приготування
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
ES2134359T3 (es) Composiciones viscoelasticas de compuestos organicos fluorados.
AR021370A1 (es) Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides
DE3587358D1 (de) Pharmazeutische zusammensetzungen.
ES2178188T3 (es) Composiciones antitusigenas que contienen teobromina.
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
AR012217A1 (es) Una composicion topica para mejorar la penetracion de compuestos farmaceuticos
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
DK0647129T3 (da) Præparat til topisk anvendelse
GEP20053581B (en) Pharmaceutical Composition and Method for Preparation Thereof
WO2001003774A3 (en) Pharmaceutical composition for the treatment of calcification
EP0992242A4 (en) PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS
MX9604984A (es) Composiciones farmaceuticas a base de derivados de la clase de los taxanos.

Legal Events

Date Code Title Description
FG Grant, registration